• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

纤溶酶原激活系统在血管性水肿中的作用:发病机制的新见解

The Role of the Plasminogen Activation System in Angioedema: Novel Insights on the Pathogenesis.

作者信息

Napolitano Filomena, Montuori Nunzia

机构信息

Department of Translational Medical Sciences and Center for Basic and Clinical Immunology Research (CISI), University of Naples Federico II, 80135 Naples, Italy.

出版信息

J Clin Med. 2021 Feb 1;10(3):518. doi: 10.3390/jcm10030518.

DOI:10.3390/jcm10030518
PMID:33535668
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7867209/
Abstract

The main physiological functions of plasmin, the active form of its proenzyme plasminogen, are blood clot fibrinolysis and restoration of normal blood flow. The plasminogen activation (PA) system includes urokinase-type plasminogen activator (uPA), tissue-type PA (tPA), and two types of plasminogen activator inhibitors (PAI-1 and PAI-2). In addition to the regulation of fibrinolysis, the PA system plays an important role in other biological processes, which include degradation of extracellular matrix such as embryogenesis, cell migration, tissue remodeling, wound healing, angiogenesis, inflammation, and immune response. Recently, the link between PA system and angioedema has been a subject of scientific debate. Angioedema is defined as localized and self-limiting edema of subcutaneous and submucosal tissues, mediated by bradykinin and mast cell mediators. Different forms of angioedema are linked to uncontrolled activation of coagulation and fibrinolysis systems. Moreover, plasmin itself can induce a potentiation of bradykinin production with consequent swelling episodes. The number of studies investigating the PA system involvement in angioedema has grown in recent years, highlighting its relevance in etiopathogenesis. In this review, we present the components and diverse functions of the PA system in physiology and its importance in angioedema pathogenesis.

摘要

纤溶酶是其酶原纤溶酶原的活性形式,其主要生理功能是溶解血凝块并恢复正常血流。纤溶酶原激活(PA)系统包括尿激酶型纤溶酶原激活剂(uPA)、组织型PA(tPA)以及两种类型的纤溶酶原激活剂抑制剂(PAI-1和PAI-2)。除了调节纤维蛋白溶解外,PA系统在其他生物学过程中也发挥着重要作用,这些过程包括细胞外基质的降解,如胚胎发生、细胞迁移、组织重塑、伤口愈合、血管生成、炎症和免疫反应。最近,PA系统与血管性水肿之间的联系一直是科学争论的主题。血管性水肿被定义为皮下和粘膜下组织的局限性自限性水肿,由缓激肽和肥大细胞介质介导。不同形式的血管性水肿与凝血和纤维蛋白溶解系统的失控激活有关。此外,纤溶酶本身可诱导缓激肽生成增强,继而引发肿胀发作。近年来,研究PA系统与血管性水肿关系的研究数量不断增加,突出了其在发病机制中的相关性。在本综述中,我们介绍了PA系统在生理学中的组成部分和多种功能及其在血管性水肿发病机制中的重要性。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4c72/7867209/cb561f22b1da/jcm-10-00518-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4c72/7867209/014017158936/jcm-10-00518-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4c72/7867209/cb561f22b1da/jcm-10-00518-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4c72/7867209/014017158936/jcm-10-00518-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4c72/7867209/cb561f22b1da/jcm-10-00518-g002.jpg

相似文献

1
The Role of the Plasminogen Activation System in Angioedema: Novel Insights on the Pathogenesis.纤溶酶原激活系统在血管性水肿中的作用:发病机制的新见解
J Clin Med. 2021 Feb 1;10(3):518. doi: 10.3390/jcm10030518.
2
Endothelial cell proteases: physiological role and regulation.内皮细胞蛋白酶:生理作用与调节
Baillieres Clin Haematol. 1993 Sep;6(3):559-76. doi: 10.1016/s0950-3536(05)80188-x.
3
Fibrinolysis: the key to new pathogenetic mechanisms.纤维蛋白溶解:新发病机制的关键。
Curr Med Chem. 2008;15(9):923-9. doi: 10.2174/092986708783955455.
4
Fibrinolysis in patients with acute ischaemic heart disease. With particular reference to systemic effects of tissue-type plasminogen activator treatment on fibrinolysis, coagulation and complement pathways.急性缺血性心脏病患者的纤维蛋白溶解。特别提及组织型纤溶酶原激活剂治疗对纤维蛋白溶解、凝血和补体途径的全身影响。
Dan Med Bull. 1993 Sep;40(4):383-408.
5
[The urokinase-type plasminogen activator system and its role in tumor progression].[尿激酶型纤溶酶原激活物系统及其在肿瘤进展中的作用]
Biomed Khim. 2018 Nov;64(6):472-486. doi: 10.18097/PBMC20186406472.
6
The Plasminogen-Activator Plasmin System in Physiological and Pathophysiological Angiogenesis.纤溶酶原激活物-纤溶酶系统在生理性和病理性血管生成中的作用。
Int J Mol Sci. 2021 Dec 29;23(1):337. doi: 10.3390/ijms23010337.
7
The fibrinolytic system: A new target for treatment of depression with psychedelics.纤维蛋白溶解系统:治疗致幻剂所致抑郁症的新靶点。
Med Hypotheses. 2017 Mar;100:46-53. doi: 10.1016/j.mehy.2017.01.013. Epub 2017 Jan 23.
8
Cytokine regulation of endothelial cell extracellular proteolysis.细胞因子对内皮细胞胞外蛋白水解的调节
Agents Actions Suppl. 1993;42:179-93. doi: 10.1007/978-3-0348-7397-0_15.
9
Biphasic regulation of plasminogen activator/inhibitor by LDL in mesangial cells.低密度脂蛋白对系膜细胞中纤溶酶原激活物/抑制剂的双相调节作用
Am J Physiol Renal Physiol. 2002 Sep;283(3):F423-30. doi: 10.1152/ajprenal.00304.2001.
10
Regulation and interactions in the activation of cell-associated plasminogen.细胞相关纤溶酶原激活中的调节与相互作用。
Cell Mol Life Sci. 2004 Nov;61(22):2840-58. doi: 10.1007/s00018-004-4230-9.

引用本文的文献

1
Unravelling the impact of SARS-CoV-2 on hemostatic and complement systems: a systems immunology perspective.从系统免疫学角度解析严重急性呼吸综合征冠状病毒2(SARS-CoV-2)对止血和补体系统的影响
Front Immunol. 2025 Jan 13;15:1457324. doi: 10.3389/fimmu.2024.1457324. eCollection 2024.
2
Plasminogen missense variants and their involvement in cardiovascular and inflammatory disease.纤溶酶原错义变体及其与心血管和炎症性疾病的关联。
Front Cardiovasc Med. 2024 Jun 25;11:1406953. doi: 10.3389/fcvm.2024.1406953. eCollection 2024.
3
The Crosstalk between N-Formyl Peptide Receptors and uPAR in Systemic Sclerosis: Molecular Mechanisms, Pathogenetic Role and Therapeutic Opportunities.

本文引用的文献

1
In Vitro Modeling of Bradykinin-Mediated Angioedema States.缓激肽介导的血管性水肿状态的体外建模
Pharmaceuticals (Basel). 2020 Aug 19;13(9):201. doi: 10.3390/ph13090201.
2
A myoferlin gain-of-function variant associates with a new type of hereditary angioedema.一种肌铁蛋白功能获得性变异与一种新型遗传性血管性水肿相关。
Allergy. 2020 Nov;75(11):2989-2992. doi: 10.1111/all.14454. Epub 2020 Jul 1.
3
An update on the genetics and pathogenesis of hereditary angioedema.遗传性血管性水肿的遗传学与发病机制最新进展
N-甲酰肽受体与 uPAR 在系统性硬化症中的串扰:分子机制、发病作用和治疗机会。
Int J Mol Sci. 2024 Mar 9;25(6):3156. doi: 10.3390/ijms25063156.
4
The Roles of Fibrinolytic Factors in Bone Destruction Caused by Inflammation.纤维蛋白溶解因子在炎症引起的骨质破坏中的作用。
Cells. 2024 Mar 15;13(6):516. doi: 10.3390/cells13060516.
5
Pathophysiology of bradykinin and histamine mediated angioedema.缓激肽和组胺介导的血管性水肿的病理生理学
Front Allergy. 2023 Oct 18;4:1263432. doi: 10.3389/falgy.2023.1263432. eCollection 2023.
6
Immunological profiling in long COVID: overall low grade inflammation and T-lymphocyte senescence and increased monocyte activation correlating with increasing fatigue severity.长新冠的免疫特征:整体低度炎症和 T 淋巴细胞衰老,以及单核细胞激活增加与疲劳严重程度增加相关。
Front Immunol. 2023 Oct 10;14:1254899. doi: 10.3389/fimmu.2023.1254899. eCollection 2023.
7
The Fibrinolytic System and Its Measurement: History, Current Uses and Future Directions for Diagnosis and Treatment.纤维蛋白溶解系统及其检测:用于诊断和治疗的历史、当前用途和未来方向。
Int J Mol Sci. 2023 Sep 16;24(18):14179. doi: 10.3390/ijms241814179.
8
Plasminogen System in the Pathophysiology of Sepsis: Upcoming Biomarkers.脓毒症病理生理学中的纤溶酶原系统:即将到来的生物标志物。
Int J Mol Sci. 2023 Aug 3;24(15):12376. doi: 10.3390/ijms241512376.
9
"Super" SERPINs-A stabilizing force against fibrinolysis in thromboinflammatory conditions.“超级”丝氨酸蛋白酶抑制剂——血栓炎症状态下对抗纤维蛋白溶解的稳定力量。
Front Cardiovasc Med. 2023 Apr 19;10:1146833. doi: 10.3389/fcvm.2023.1146833. eCollection 2023.
10
Managing Diagnosis, Treatment, and Burden of Disease in Hereditary Angioedema Patients with Normal C1-Esterase Inhibitor.管理C1酯酶抑制剂水平正常的遗传性血管性水肿患者的诊断、治疗和疾病负担
J Asthma Allergy. 2023 Apr 22;16:447-460. doi: 10.2147/JAA.S398333. eCollection 2023.
Genes Dis. 2019 Aug 1;7(1):75-83. doi: 10.1016/j.gendis.2019.07.002. eCollection 2020 Mar.
4
Therapeutics targeting the fibrinolytic system.靶向纤维蛋白溶解系统的治疗方法。
Exp Mol Med. 2020 Mar;52(3):367-379. doi: 10.1038/s12276-020-0397-x. Epub 2020 Mar 9.
5
Plasminflammation-An Emerging Pathway to Bradykinin Production.纤溶炎症——缓激肽产生的新途径。
Front Immunol. 2019 Aug 27;10:2046. doi: 10.3389/fimmu.2019.02046. eCollection 2019.
6
Identification of the recently described plasminogen gene mutation p.Lys330Glu in a family from Northern Germany with hereditary angioedema.在一名来自德国北部、患有遗传性血管性水肿的家族中鉴定出最近描述的纤溶酶原基因突变p.Lys330Glu 。
Clin Transl Allergy. 2019 Feb 14;9:9. doi: 10.1186/s13601-019-0247-x. eCollection 2019.
7
Isolated angioedema: An overview of clinical features and etiology.孤立性血管性水肿:临床特征与病因概述
Exp Ther Med. 2019 Feb;17(2):1068-1072. doi: 10.3892/etm.2018.6982. Epub 2018 Nov 16.
8
On the pathogenicity of the plasminogen K330E mutation for hereditary angioedema.纤溶酶原K330E突变对遗传性血管性水肿的致病性研究
Allergy. 2018 Aug;73(8):1751-1753. doi: 10.1111/all.13324.
9
A missense mutation of the plasminogen gene in hereditary angioedema with normal C1 inhibitor in Japan.日本遗传性血管性水肿伴正常C1抑制剂的纤溶酶原基因错义突变。
Allergy. 2018 Nov;73(11):2244-2247. doi: 10.1111/all.13550. Epub 2018 Aug 13.
10
Regulation of plasminogen activation on cell surfaces and fibrin.细胞表面和纤维蛋白上纤溶酶原激活的调节
J Thromb Haemost. 2018 May 20;16(8):1487-97. doi: 10.1111/jth.14157.